Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

QuidelOrtho Corp

QDEL Clue Score37
United States Fiscal year ends January CIK 0001906324 Results filed 3 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Brian J. Blaser
13 Feb 2026
President and CEO
Buy indirect
10,540
$23.59
$248.66K
Joseph M. Busky
13 Feb 2026
Chief Financial Officer
Buy indirect
3,370
$23.66
$79.74K
Matthew Strobeck
13 Feb 2026
Director
Buy
10,000
$23.96
$239.59K
Ann D Rhoads
10 Dec 2025
Director
Buy
750
$28.28
$21.21K
Joseph D Wilkins Jr.
26 Nov 2025
Director
Buy
370
$27.96
$10.34K
Joseph M. Busky
24 Nov 2025
Chief Financial Officer
Buy indirect
4,770
$26.06
$124.31K
Mary Lake Ph D Polan
21 Nov 2025
Director
Buy
1,000
$22.43
$22.43K
Brian J. Blaser
19 Nov 2025
President and CEO
Buy indirect
23,500
$21.34
$501.58K
Brian J. Blaser
11 Dec 2024
President and CEO
Buy indirect
6,033
$41.42
$249.88K
Joseph M. Busky
23 Feb 2024
Chief Financial Officer
Buy indirect
2,150
$46.36
$99.66K

What was left out

Form 4 filings counted 302
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 22
Sales on a Rule 10b5-1 plan 103
Sales straight out of an exercise 2
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 1,666,714
History held since 1 Jun 2022